Influence of Central Noradrenergic System Lesion on the Serotoninergic 5-HT3 Receptor Mediated Analgesia in Rats
Journal Title: Advances in Clinical and Experimental Medicine - Year 2013, Vol 22, Issue 5
Abstract
<strong>Background. </strong>Monoaminergic pathways, impinging an adrenergic and 5-HT3 serotonin receptors, modulate nociceptive transmission, but their mechanisms and interactions has not been clarified yet.<br /><strong>Objectives. </strong>The study was designed to investigate the influence of the neonatal noradrenergic system lesion on the antinociceptive effect of 5-HT3 receptor ligands assessed in adult animals.<br /><strong>Material and Methods. </strong>Intact male rats were contrasted with rats in which noradrenergic nerve terminals were largely destroyed shortly after birth with neurotoxin DSP-4 [(N-(-2-chloroethyl)-N-ethyl-2-bromobenzylamine; 50 mg/kg × 2 subcutaneously (<em>sc</em>)], on the 1st and 3rd days of postnatal life. Control animals were injected with saline (1.0 mL/kg sc). When the rats attained 10 weeks of age, painful reactions were assessed by means of writhing and formalin tests after intraperitoneal (<em>ip) </em>administration of 1-phenylbiguanid (FBG; 7.5 mg/kg) or ondansetrone (1.0 mg/kg) with FBG (7.5 mg/kg). Morphine was used as a model analgesic drug.<br /><strong>Results. </strong>Injections of morphine (7.5 mg/kg <em>sc</em>) evoked similar antinociception in the visceral pain model (writhing test) in both tested groups (control and DSP-4). In control rats, a 5-HT3 receptor agonist FBG (7.5 mg/kg) elicited analgesia similar to that of morphine but the effect was significantly lower in DSP-4 treated animals. A 5-HT3 receptor antagonist ondansetrone (1.0 mg/kg) injected before FBG did not modify the effect in the control but suppressed it in the DSP-4 group. In the formalin test, morphine produced higher analgesia in control rats in comparison with the DSP-4 group (pain intensity score of 1 point vs. 2-3 points, respectively). Ondansetrone injected before FBG alleviated the observed effect.<br /><strong>Conclusions. </strong>Based on the obtained results, we concluded that the neonatal DSP-4 treatment alters the antinociceptive effects of morphine and serotoninergic 5-HT3 receptor ligands. The above may explain altered (diminished) reactions of analgesics applied to patients with noradrenergic system dysfunction (e.g. depression and/or anxiety disorders<strong>)</strong>.
Authors and Affiliations
Wojciech Roczniak, Justyna Wróbel, Ludmiła Dolczak, Przemysław Nowak
Keywords
Related Articles
- EP ID EP157150
- DOI -
- Views 123
- Downloads 0
Normatywne dane na temat wzrostu średnic zewnętrznych tętnic biodrowych zewnętrznych i wewnętrznych u płodów ludzkich - badanie anatomiczne, cyfrowe i statystyczne
[b]Wprowadzenie.[/b] Dane normatywne dotyczące średnic segmentu aortalno-biodrowego są bardzo użyteczne w rozpoznaniu i monitorowaniu wariantów i patologii tętnic w okresie prenatalnym. [b]Cel pracy.[/b] Praca ta opisuj...
Bakteriobójcza aktywność normalnej surowicy ludzkiej wobec szczepów z rodziny Enterobacteiaceae z lipopolisacharydami zawierającymi O-antygeny typu mannanowego
[b]Streszczenie [/b] [b]Wprowadzenie.[/b] Podatność bakterii na bakteriobojcze działanie surowicy zależy od struktury i organizacji błony zewnętrznej drobnoustroju. Wiadomo, że struktura polisacharydowego łańcucha O-swo...
Zależność między p53/topoizomerazą I i p53/topoizomerazą IIα immunofenotypem a progresją raka jajnika
[b]Wprowadzenie.[/b] Badania in vitro wykazały, że białko p53 reguluje stężenie topoizomerazy I (topo I) i topoizomerazy II (topo II) w komórkach nowotworowych. W rakach jajnika nie prowadzono analizy związków między top...
Proteomic Analysis of the Immunosuppressive Effects of Mesenchymal Stem Cells in a Rat Heart Transplantation Model
<strong>Background. </strong>Some reports suggest mesenchymal stem cells (MSCs) have immunosuppressive properties. However, conflicting evidence regarding the role of MSCs has emerged.<br /><strong>Objectives. </strong>T...
Kalcytonina i prokalcytonina u pacjentów z rakiem rdzeniastym tarczycy lub infekcją bakteryjną
[b]Cel pracy.[/b] Ocena przydatności prokalcytoniny jako markera raka rdzeniastego tarczycy. [b]Materiał i metody.[/b] Stężenia kalcytoniny i prokalcytoniny zmierzono u pacjentów z rakiem rdzeniastym tarczycy lub ciężką...